SCHEMBL5534154

SCHEMBL5534154

N#CCNC(=O)C(CNC(=O)c1cccs1)C1CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 3/20 0.53
RAB9A P51151 6/20 0.49
NPC1 O15118 4/20 0.49
HPGD P15428 4/20 0.49
TSHR P16473 3/20 0.49
ALDH1A1 P00352 2/20 0.49
MEN1 O00255 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C19 P33261 1/20 0.49
KMT2A Q03164 1/20 0.49
CTSB P07858 2/20 0.48
CTSS P25774 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
CTSC P53634 1/20 0.46
CTSK P43235 1/20 0.44
HSD17B10 Q99714 1/20 0.44
GAA P10253 1/20 0.43
GLA P06280 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5521693 0.84 CTSL (0.53) CTSLRAB9ANPC1HPGDTSHR
SCHEMBL5525342 0.83 CTSL (0.60) CTSLRAB9AALDH1A1CYP1A2CYP2D6
SCHEMBL5528198 0.83 CTSL (0.46) CTSLRAB9ANPC1HPGDTSHR
SCHEMBL5520849 0.82 CTSL (0.45) CTSLRAB9AMEN1KMT2ACTSB
SCHEMBL5524187 0.82 NPC1 (0.46) CTSLRAB9ANPC1ALDH1A1KMT2A
SCHEMBL5527081 0.81 CTSL (0.44) CTSLALDH1A1MEN1KMT2ACTSB
SCHEMBL5525370 0.81 OPRM1 (0.47) CTSLRAB9ANPC1ALDH1A1MEN1
SCHEMBL5530581 0.81 OPRM1 (0.64) CTSLRAB9ACTSBCTSSCTSK
SCHEMBL5532499 0.80 CTSL (0.48) CTSLRAB9ANPC1HPGDCTSB
SCHEMBL7564802 0.80 CTSL (0.46) CTSLCTSBCTSSCTSKGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070015755-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2007-01-18 US disclosed
US-20040147745-A1 Novel compounds and compositions as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2004-07-29 US disclosed
EP-1178958-B1 N-CYANOMETHYL AMIDES AS PROTEASE INHIBITORS AXYS PHARM INC (US) 2004-02-18 EP disclosed
US-20030096796-A1 Novel compounds and compositions as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2003-05-22 US disclosed
US-6455502-B1 Compounds and compositions as protease inhibitors AXYS PHARMACEUTICALS, INC. 2002-09-24 US disclosed
EP-1178958-A2 N-CYANOMETHYL AMIDES AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2002-02-13 EP disclosed
WO-2000055125-A2 N-CYANOMETHYL AMIDES AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2000-09-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096796-A1 Novel compounds and compositions as protease inhibitors CTRL, SERPINB1, CPN1 CTSL 14/4885RAB9A 2240/4885NPC1 545/4885
US-20040147745-A1 Novel compounds and compositions as protease inhibitors CTRL, SERPINB1, CPN1 CTSL 14/4885RAB9A 2240/4885NPC1 545/4885
US-20070015755-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS CTRL, SERPINB1, CPN1 CTSL 14/4885RAB9A 2240/4885NPC1 545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.